EnVVeno Medical to Showcase Its Innovations in an Upcoming Virtual Investor Event

enVVeno Medical Corporation, a trailblazer for venous disease treatment, announces its participation in the Virtual Investor Lunch Break titled "The enVVeno Opportunity". This event is scheduled for Thursday, March 21, 2024, at 12:00 PM ET, where enVVeno's CEO, Robert Berman, will lead a presentation.

Berman intends to provide an in-depth corporate overview, articulate the business outlook, and elaborate on what he terms "the enVVeno Opportunity". This session aims to illuminate the company's forward trajectory and current ventures in the medical field, particularly its innovative approaches to treating venous diseases.

The presentation will be broadcast live via a video webcast, accessible from the Events section of enVVeno's website. Those unable to attend the live session will benefit from a replay option available on the website, starting two hours post-event and extending for a subsequent 90 days.